An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization
Clinical trial NCT04215393 · UNKNOWN
Trial details
- NCT number
- NCT04215393
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-18
- Primary completion
- 2020-04-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.